
Australian healthcare stocks .AXHJ slip 1.2% to a one-week low, extending declines from previous session
Vaccine maker CSL CSL.AX down 1.8%; biopharma Telix TLX.AX drops 3.3%
US President Trump signs executive order aiming to reduce approval time for local pharma plants to encourage domestic manufacturing; plans pharma tariffs in next two weeks
Australian healthcare firms largely depend on exports to the U.S. and are hurt by a strong Australian dollar, which has hit a new five-month peak. AUD/